SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-042906
Filing Date
2024-05-14
Accepted
2024-05-14 16:00:56
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0204707-10q_hoththerap.htm   iXBRL 10-Q 508042
2 CERTIFICATION ea020470701ex31-1_hoththerap.htm EX-31.1 10045
3 CERTIFICATION ea020470701ex31-2_hoththerap.htm EX-31.2 10057
4 CERTIFICATION ea020470701ex32-1_hoththerap.htm EX-32.1 3611
5 CERTIFICATION ea020470701ex32-2_hoththerap.htm EX-32.2 3706
  Complete submission text file 0001213900-24-042906.txt   4124535

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hoth-20240331.xsd EX-101.SCH 56521
7 XBRL CALCULATION FILE hoth-20240331_cal.xml EX-101.CAL 25441
8 XBRL DEFINITION FILE hoth-20240331_def.xml EX-101.DEF 229302
9 XBRL LABEL FILE hoth-20240331_lab.xml EX-101.LAB 419526
10 XBRL PRESENTATION FILE hoth-20240331_pre.xml EX-101.PRE 228333
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0204707-10q_hoththerap_htm.xml XML 398489
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 24944046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)